Option Chain

Alumis Inc

ALMSNASDAQ · USD

6.03USD+0.18 (+3.08%)

1210

Alumis Inc (ALMS) Option Chain

Alumis Inc trades at $6.03, up 3.08%, with an IV Rank of 53.17%. This is average versus the past year, and the company carries a market cap of $781M in the Biotechnology industry. On the Nov 20, 2026 chain, the at the money $6.00 strike shows calls at $0.05 / $0.70 and puts at $0.20 / $0.65, both carrying about $0.38 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $8.00 calls, at 6 contracts, and the $5.00 puts, at 400, as of Nov 5, 2026.

Tracking the ALMS option chain helps you see every strike and expiry on Alumis Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ALMS options activity at a glance. Use our scanner to monitor the ALMS option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ALMS stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ALMS options are being actively traded, and where they are not.

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. It develops ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis, systemic lupus erythematosus, and non-infectious uveitis; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor for neuroinflammatory and neurodegenerative diseases. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. The company was incorporated in 2021 and is headquartered in South San Francisco, California.

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
6.38	0	0	0.69	2.03	0.55	4.90	4.00	-31.62	—	4.90	0.00	4.90	0	0	93.62
28.60	9	0	1.44	1.03	0.05	4.90	5.00	-14.53	—	0.20	0.00	0.20	400	0	71.40
58.64	310	1	0.34	0.03	0.05	0.70	6.00	+2.56	0.20	0.65	0.00	0.43	46	491	41.36
81.07	1,305	0	0.45	0.00	—	0.45	7.00	+19.66	0.90	1.60	0.97	0.28	0	268	18.93
92.70	476	6	0.35	0.00	—	0.35	8.00	+36.75	0.85	4.90	1.97	0.91	0	131	7.30

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

IndustryBiotechnology
SectorHealthcare
IV Rank53.17% Moderate
Market cap (M$)781
52 weeks high-81.34%
52 weeks low32.95%
Analyst recommendationStrong Buy
1.30
Target price$31.12
416.09% above the current stock price
Dividend—
Payout ratio—
Earnings date2026-11-12
P/E—
Future P/E—
EPS (ttm)-3.81
EPS growth next 5 years10.01%

As of Nov 5, 2026

Browse all Option Chain tickers